Call toll-free 800.328.1267
Everybody talks about buying the pullback, but sometimes it's easier said than done. Fortunately, TradeStation's desktop and web platforms include several tools for investors looking to follow trends. This information-packed educational video demonstrates how...
Amazon.com has retraced almost all of its pandemic gains. Is this an opportunity for buyers? Let's consider some chart patterns. First is the $101.79 level (split adjusted). It was a peak in July 2019 and a breakout area immediately before the coronavirus selloff in...
Stocks fell again last week as recession worries increased, but there could be some positives as the second half begins. The S&P 500 fell 2.2 percent between Friday, June 24, and Friday, July 1. The decline finished another negative quarter, however a bigger story...
The technology sector just had its worst quarter in 14 years. Every member declined in the period -- except for July's mystery stock. The SPDR Technology Sector ETF (XLK) fell 20 percent between March 31 and June 30 -- its worst quarterly performance since late 2008....
Advanced Micro Devices made new lows in June, but it remained the most actively traded symbol at TradeStation Securities for the fifth straight month. AMD declined as investors shunned economically sensitive semiconductor stocks. It's lost more than half its value...
The broader market has been super volatile lately, which makes the tranquil behavior of one retailer interesting: Dollar Tree. Notice how the discounter plunged on May 18 after Target's (TGT) poor quarterly results. Also notice how quickly it rebounded after its own...
Investors just pivoted back to growth stocks as inflation worries fade and a new quarter approaches. The S&P 500 jumped 6.4 percent in the holiday-shortened week between Friday, June 17, and Friday, June 20. More than 95 percent of the index's members advanced,...
2022 has been a difficult year for many investors as technology stocks retreat and inflation surges. Despite the volatility, there have been clear patterns based on company fundamentals and macroeconomic factors. Traders aware of certain cues could potentially benefit...
United Therapeutics spent more than a year consolidating around its 2015 highs. Now the biotech may be attempting a breakout. Notice the surge to new all-time highs late last month. The rally followed news that the Food & Drug Administration approved its Tyvaso...